What is the appropriate initial evaluation and management for acute colitis?

Acute Colitis: Initial Evaluation and Management

For hospitalized patients with acute severe ulcerative colitis (ASUC), immediately start intravenous methylprednisolone 40-60mg daily (or hydrocortisone 100mg four times daily), obtain urgent blood work (CBC, CRP, electrolytes, LFTs with albumin), stool cultures including Clostridioides difficile testing, and initiate VTE prophylaxis 1, 2.

Initial Risk Stratification

Use Truelove and Witts' criteria to identify ASUC requiring hospitalization 1:

• ≥6 bloody stools per day, PLUS at least one of:
  • Heart rate >90 bpm
  • Temperature >37.8°C
  • Hemoglobin <105 g/L
  • ESR >30 mm/h or elevated CRP

This is a medical emergency with 1% mortality risk 1. Approximately 20% will require colectomy during the same admission 1.

Immediate Diagnostic Workup

Laboratory Testing

Obtain urgently 1:

• Complete blood count (assess anemia, leukocytosis)
• CRP (baseline severity marker)
• Electrolytes and renal function
• Liver function tests including albumin
• Stool culture and C. difficile testing (mandatory to exclude infection)

Imaging and Endoscopy

• Flexible sigmoidoscopy (not full colonoscopy due to perforation risk) 1
• Non-invasive imaging to assess colonic dilation and exclude complications 1
• Consider CMV testing in steroid-refractory cases (though adherence historically low at 30%) 3

Critical Pitfall

Never delay treatment waiting for infectious workup results—start IV corticosteroids immediately while awaiting cultures 1.

First-Line Treatment: Intravenous Corticosteroids

Use methylprednisolone 40-60mg daily OR hydrocortisone 100mg four times daily 1, 2:

• Methylprednisolone preferred (less mineralocorticoid effect, less hypokalemia) 1
• Higher doses provide no additional benefit and increase toxicity 2
• Approximately 67% respond to IV steroids 1

Treatment Duration

• Assess response at 72 hours using validated criteria 4
• Switch to oral steroids when clinically appropriate (usually within 7 days) 1
• Do not continue IV steroids beyond 7-10 days—no additional benefit and increased toxicity 1, 2

Essential Supportive Measures

VTE Prophylaxis

Administer anticoagulant prophylaxis to all patients—ASUC carries increased thrombosis risk and prophylaxis does not precipitate colonic bleeding 1. This is frequently missed (only 43% adherence in recent audits) 3.

Antibiotics

Do not use adjunctive antibiotics unless specific infection identified 2. Routine antibiotic use is not recommended.

Specialist Consultation

• Gastroenterology consultation in 98% of cases 3
• Early colorectal surgery assessment for steroid-refractory patients or complications 4

Steroid-Refractory Disease (33% of patients)

If no response by day 3-5 1, 4:

Second-Line Rescue Therapy Options

Infliximab (traditional first choice):

• Standard dosing or accelerated/intensified regimens for high inflammatory burden 5
• Equally effective as cyclosporine 4

Cyclosporine 2mg/kg:

• Requires specific monitoring and precautions 6
• Equally effective as infliximab 4

Choice between infliximab and cyclosporine should be individualized based on:

• Prior anti-TNF exposure (if failed, consider cyclosporine or JAK inhibitor)
• Comorbidities and contraindications 4
• Local expertise

Emerging Options

JAK inhibitors (tofacitinib, upadacitinib):

• Rapid onset (as early as 1 day) 7
• Promising efficacy in steroid-refractory ASUC 5, 7
• Upadacitinib shows promise when standard/intensified infliximab fails 5
• Evidence still limited but growing 4

Surgical Intervention

Indications for urgent colectomy 6, 4:

• Perforation
• Massive hemorrhage
• Toxic megacolon
• Failure of medical rescue therapy

Procedure of choice: Subtotal colectomy with ileostomy and rectosigmoid mucous fistula 6—minimizes septic complications while preserving future reconstructive options.

Key Clinical Pitfalls

1. Underestimating severity—use objective criteria, not clinical impression alone 8
2. Forgetting VTE prophylaxis—only 43% adherence despite clear guidelines 3
3. Inadequate infection screening—CMV testing only 30% adherence 3
4. Prolonging ineffective steroids—reassess at 72 hours, don't wait beyond 7-10 days 1, 2
5. Delayed surgical consultation—involve surgery early in steroid-refractory cases 4

Differential Diagnosis Considerations

While managing presumed ASUC, remain vigilant for 9, 10:

• Infectious colitis (bacterial, viral, parasitic)
• Ischemic colitis (especially in elderly, vascular disease)
• Drug-induced colitis
• Neutropenic colitis (immunocompromised patients)

The diagnostic approach with stool studies, endoscopy with biopsies, and clinical context helps distinguish these 9.